BANDO Hiroko
- Articles
- Clinical Utility of Integrated Multidisciplinary Patient-Centered Information in Breast Cancer Care: A Mixed Methods Study
Sugiyama Atsuko; Utsunomiya Kazuki; Fujimoto Katsuhiko...
Journal of multidisciplinary healthcare/18/pp.1875-1893, 2025-04-01 - HLA class II-restricted T cell epitopes in public neoantigens of ESR1 and PIK3CA in breast cancer
Ando Yukari; Miyadera Hiroko; Bando Hiroko; Hashimoto ...
BMC cancer/25(1)/p.610, 2025-04-04 - Sentinel lymph node biopsy in clinical T3-4c breast cancer: A retrospective multicenter cohort study
Sagara Y.; Kuba S.; Maeda S.; Yano H.; Sakai T.; Koj...
ANNALS OF ONCOLOGY/35(2)/pp.S349-S349, 2024-09 - Tumor Immunoregulatory Mechanisms by Nonmetastatic Melanoma Protein B in Triple Negative Breast Cancer
Kawanishi Kunio; Dangcao Thuylinh; Okita Yukari; Watan...
CANCER SCIENCE/116(1:SI)/pp.664-664, 2025-01 - Exploration of therapeutic target molecules for triple negative breast cancer by spatial transcriptome analysis
Shiratani Rie; Kawanishi Kunio; Hengphasatporn Kowit; ...
CANCER SCIENCE/116(1:SI)/pp.472-472, 2025-01 - Efficacy and Safety of Mirogabalin Therapy for Paclitaxel-Induced Peripheral Neuropathy (MICHEL Study): A Pilot Study
Sawa Aya; Bando Hiroko; Sato Riko; Matsuo Tomohei; Ok...
Oncology/pp.1-12, 2025-02-03 - Spatially Resolved Single-Cell Transcriptomics of T Cells in Follicular Lymphoma Reveals Distinct Immune Ecosystems
Abe Yoshiaki; Zenkoh Junko; Kanai Akinori; Ikeda Dais...
BLOOD/144(1)/pp.741-742, 2024-11-05 - Single-cell survey reveals minor cell subsets in lymphoma microenvironment
Abe Yoshiaki; Zenkoh Junko; Fujisawa Manabu; Miyoshi ...
CANCER SCIENCE/115(1)/pp.352-352, 2024-03 - Exploration of public neoantigen in breast cancer that could be an HLA class II restricted T cell epitope
Ando Yukari; Miyadera Hiroko; Hashimoto Sachie; Hara ...
CANCER SCIENCE/115(1)/pp.834-834, 2024-03 - RWE（real world evidence）の創出とその意義
坂東 裕子
日本臨牀増刊号 乳癌学2024下/82(7)/pp.261-266, 2024-9-30 - Examining the association between patient-reported outcomes and physical activity metrics in patients with HR1/ HER2 advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone
Oba Mari S.; Miyaji Tempei; Bando Hiroko; Ueda Aya; T...
QUALITY OF LIFE RESEARCH/33(1)/pp.S40-S41, 2024-10 - 当院における甲状腺分化癌と良性症例の腫瘍径とサイログロブリン値の傾向
蒲原 玲南; 井口 研子; 大谷 光; 柳瀬 友里菜; 渡邊 瑞穂; 佐藤 璃子; 松尾 知平; 上...
第36回日本内分泌外科学会総会抄録集/41(180)/pp.S227-S227, 2024/4 - 当院における副甲状腺癌の術前診断と術後経過に関する検討
松尾 知平; 井口 研子; 柳瀬 友里菜; 大谷 光; 渡邊 瑞穂; 蒲原 玲南; 佐藤 璃子; 上...
第36回日本内分泌外科学会総会抄録集/41(180)/pp.S195-S195, 2024/4 - 腎移植患者で副甲状腺機能亢進症に対する手術過料を行った2例の検討
柳瀬 友里菜; 佐藤 璃子; 井口 研子; 大谷 光; 渡邊 瑞穂; 蒲原 玲南; 松尾 知平; 上...
第36回日本内分泌外科学会総会抄録集/41(180)/pp.S235-S235, 2024/4 - アベマシクリブ治療を受ける乳がん患者と医師のコミュニケーションに関するオンライン調査
井関千裕; 鳥口尚子; 谷澤欣則; 関根信幸; 水野聖子; 大佐賀智; 坂東 裕子
癌と化学療法/51(12)/pp.1227-1237, 2024-12 - ホルモン受容体陽性・ヒト上皮成長因子受容体2型陰性乳癌の内分泌療法における治療選好とアンメットニーズ：患者・医師サーベイ研究
坂東 裕子; 飯田真由美; 谷澤欣則; 大佐賀智; 三浦萌実; 中川圭; 川口耕; 徳永えり子
新薬と臨牀/73(9)/pp.855-881, 2024-9 - 腫瘍塞栓性肺微小血管障害(PTTM)により急速な転機をたどった転移乳癌の一例
塚田実花子; 橋本幸枝; 高橋ひかる; 濱岡 武; 蒲原玲南; 松尾知平; 岡崎 舞; 井口研子; 坂東裕子; ...
第20回 日本乳癌学会関東地方会 プログラム・抄録集/pp.141-141, 2024-12-7 - 乳癌治療開始前に妊孕性温存療法を行い妊娠・出産に至った1例
高橋ひかる; 坂東裕子; 濱岡 武; 蒲原玲南; 松尾知平; 岡崎 舞; 橋本幸枝; 井口研子; 原 尚人
第20回 日本乳癌学会関東地方会 プログラム・抄録集/pp.129-129, 2024-12-7 - Neoadjuvant hormonal therapy plus palbociclib versus hormonal therapy plus placebo in women with operable, hormone sensitive and HER2-negative primary breast cancer
Takkayuki Ueno; Chow Louis W.C.; Han Wonshik; Haung C...
2022 SABCS/83(5), 2023/3/1 - Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumors
Nishimura Tomomi; Velaga Ravi; Masuda Norikazu; Kawagu...
CANCER SCIENCE/Epub, 2024-10-07 - Consideration of factors of low accrual and methods for setting appropriate accrual periods: Japan Clinical Oncology Group study
Sasaki Keita; Mizusawa Junki; Bando Hiroko; Nakamura ...
TRIALS/25(1), 2024-10-08 - ホルモン受容体陽性・ヒト上皮成長因子受容体2型陰性乳癌の内分泌療法における治療選好とアンメットニーズ：患者・医師サーベイ研究
坂東 裕子
新薬と臨床/73(9)/pp.855-881, 2024/09 - Clinical Experience with Simultaneous Mixed Infusion of Trastuzumab and Pertuzumab in the Neo-Peaks Study (JBCRG-20 Sub-Study)
Hiroko Bando; Hiroyuki Yasojima; Kazushige Ishida; Kok...
Japanese Journal of Cancer and Chemotherapy/51(9)/pp.925-930, 2024/09 - TP53 signature predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: Observational and confirmational study using prospective study cohorts
Takahashi Shin; Sato Nobuaki; Kaneko Kouji; Masuda No...
TRANSLATIONAL ONCOLOGY/48, 2024-10 - Effective disruption of cancer cell membranes by photodynamic therapy with cell membrane-adhesive photosensitizer
Hoshi Aoi; Yoshitomi Toru; Komatsu Yoshiki; Kawazoe N...
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION/Epub, 2024-08-24 - more...
- Clinical Utility of Integrated Multidisciplinary Patient-Centered Information in Breast Cancer Care: A Mixed Methods Study